Isaka Y - Search Results

1

Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats.

Shimomura A, Matsui I, Hamano T, Ishimoto T, Katou Y, Takehana K, Inoue K, Kusunoki Y, Mori D, Nakano C, Obi Y, Fujii N, Takabatake Y, Nakano T, Tsubakihara Y, Isaka Y, Rakugi H. Shimomura A, et al. Among authors: isaka y. J Am Soc Nephrol. 2014 Sep;25(9):1954-65. doi: 10.1681/ASN.2013090967. Epub 2014 Mar 20. J Am Soc Nephrol. 2014. PMID: 24652795 Free PMC article.

2

Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.

Imai E, Takenaka M, Isaka Y, Moriyama T, Akagi Y, Kakuchi J, Fujii T, Ito T, Hori M, Horio M, Syoji T, Tsubakihara Y. Imai E, et al. Among authors: isaka y. Clin Exp Nephrol. 2003 Jun;7(2):113-9. doi: 10.1007/s10157-002-0220-0. Clin Exp Nephrol. 2003. PMID: 14586729

3

Gene therapy in renal diseases.

Imai E, Takabatake Y, Mizui M, Isaka Y. Imai E, et al. Among authors: isaka y. Kidney Int. 2004 May;65(5):1551-5. doi: 10.1111/j.1523-1755.2004.05409.x. Kidney Int. 2004. PMID: 15086890 Free article. Review.

4

Electroporation-mediated HGF gene transfer ameliorated cyclosporine nephrotoxicity.

Mizui M, Isaka Y, Takabatake Y, Mizuno S, Nakamura T, Ito T, Imai E, Hori M. Mizui M, et al. Among authors: isaka y. Kidney Int. 2004 Jun;65(6):2041-53. doi: 10.1111/j.1523-1755.2004.00625.x. Kidney Int. 2004. PMID: 15149317 Free article.

5

DNAzyme for TGF-beta suppressed extracellular matrix accumulation in experimental glomerulonephritis.

Isaka Y, Nakamura H, Mizui M, Takabatake Y, Horio M, Kawachi H, Shimizu F, Imai E, Hori M. Isaka Y, et al. Kidney Int. 2004 Aug;66(2):586-90. doi: 10.1111/j.1523-1755.2004.00777.x. Kidney Int. 2004. PMID: 15253710 Free article.

6

[Risedronate: a possible treatment for extraosseous calcification].

Fujii N, Hamano T, Isaka Y, Ito T, Imai E. Fujii N, et al. Among authors: isaka y. Clin Calcium. 2005 Sep;15 Suppl 1:75-8; discussion 78-9. Clin Calcium. 2005. PMID: 16272635 Japanese.

7

[RNAi gene therapy for kidney disease].

Isaka Y, Takabatake Y, Imai E. Isaka Y, et al. Nihon Rinsho. 2006 Feb;64 Suppl 2:659-61. Nihon Rinsho. 2006. PMID: 16523972 Review. Japanese. No abstract available.

8

Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease.

Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Okada N, Imai E, Horio M, Ito T. Hamano T, et al. Among authors: isaka y. Bone. 2006 Nov;39(5):1067-1072. doi: 10.1016/j.bone.2006.04.022. Epub 2006 Jun 16. Bone. 2006. PMID: 16781904

9

Targeting of interstitial cells using a simple gene-transfer strategy.

Fujii N, Isaka Y, Takabatake Y, Mizui M, Suzuki C, Takahara S, Ito T, Imai E. Fujii N, et al. Among authors: isaka y. Nephrol Dial Transplant. 2006 Oct;21(10):2745-53. doi: 10.1093/ndt/gfl327. Epub 2006 Jul 5. Nephrol Dial Transplant. 2006. PMID: 16822795

10

Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).

Fujii N, Hamano T, Mikami S, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Imai E, Hori M, Ito T. Fujii N, et al. Among authors: isaka y. Nephrol Dial Transplant. 2007 Jun;22(6):1601-7. doi: 10.1093/ndt/gfl567. Epub 2006 Nov 23. Nephrol Dial Transplant. 2007. PMID: 17124283 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters